FilingSEC EDGAR6-K
XORTX Prepares Clinical Trial Application for Gout Drug XRx-026 in Canada
· SEC accepted
Stageclinical_trial
Filing content
The company plans to file a Clinical Trial Application with Health Canada for its gout program XRx-026 to accelerate clinical data delivery.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…